Mental Health Acquisitions

A small but significant acquisition is highlighted as Braxia Scientific buys Ketamd for $6 million, emphasizing the growing acceptance of alternative mental health treatments. The conversation reveals how startups are finding liquidity through smaller deals, and the shift towards a broader understanding of mental health care is becoming a normalized part of societal discourse.